Treatment of metastatic breast cancer with somatostatin analogues--a meta-analysis

Somatostatin analogues appear to have antiproliferative effects in breast cancer by inhibiting various hormones. Several small phase 1 and 2 clinical trails have evaluated the efficacy of somatostatin analogues, but the results are varied. The purpose of this study was to use the technique of meta-a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2001-04, Vol.8 (3), p.227-233
Hauptverfasser:	Dolan, J T, Miltenburg, D M, Granchi, T S, Miller, 3rd, C C, Brunicardi, F C
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Hormonal - adverse effects Antineoplastic Agents, Hormonal - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - pathology Female Humans Insulin-Like Growth Factor I - drug effects Octreotide - adverse effects Octreotide - analogs & derivatives Octreotide - therapeutic use Peptides, Cyclic - adverse effects Peptides, Cyclic - therapeutic use Somatostatin - adverse effects Somatostatin - analogs & derivatives Somatostatin - therapeutic use Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!